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A B S T R A C T
Objective: Lactobacilli have been found in the neovagina of very low numbers of transsexual women. We
undertook this study to determine whether an orally administered preparation of four lactobacilli strains
exerts some measurable effect on the neovaginal microflora of female transsexuals.
Study design: 60 male to female transsexual women with penile linked neovagina were randomised into
two groups. Women in the intervention group (n = 33) received oral probiotic capsules and women in the
control group (n = 27) placebo in for 7 days. Swabs of the neovagina were taken before and after the
therapy.
Results: Comparing the first and second swabs, we observed a significant improvement of the Nugent
score in the intervention group 16 (48.5%) vs. low improvement in control group 4 (14.8%) (p < 0.006).
The neovaginal microflora was significantly enriched with lactobacilli after oral supplementation
compared to placebo. In the intervention group, an increase by 10,000  600 colony forming units (CFU) of
presumptive lactobacilli was observed, compared with an increase by 1600  100 CFU in the control group
(p < 0.0001). When measured by real-time PCR (c/ml), lactobacilli increased by 1400  100 c/ml in the
intervention group and 300  100 c/ml in the control group (p < 0.0001).
Conclusion: There was an improvement of vaginal lactobacilli microflora after of oral supplementation
with lactobacilli strains in transsexual women.
 2013 Elsevier Ireland Ltd. All rights reserved.
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The microflora of male to female transsexual women is a
complex symbiosis of aerobic and anaerobic species with a very
limited number of lactobacilli. It has substantial similarity to the
abnormal vaginal microflora characteristic of bacterial vaginosis
(BV) [1,2]. Weyers et al. reported that, although transsexual
women show serum oestradiol levels comparable to those of
postmenopausal women taking oestrogen replacement therapy,
their neovaginal environment does not support the growth of
lactobacilli [1]. In one study [1], only one of thirty transsexual
women had neovaginal colonisation with lactobacilli. Another
study of transsexual women, the same authors [2] found a
neovaginal lactobacilli colonisation rate of 4%.* Corresponding author at: Department of Obstetrics and Fetomaternal Medicine,
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http://dx.doi.org/10.1016/j.ejogrb.2013.10.019Several bacterial species are able to colonise both the
gastrointestinal and reproductive tracts. The rectum may play
an important role as a source of organisms that colonise the vagina
[3]. The gut has been suggested as a reservoir for vaginal
colonisation by Lactobacillus spp., thereby contributing to the
maintenance of a normal vaginal microbiota [4,5]. A recent study
has shown that 80% of pregnant women and 40% of postmeno-
pausal women had the same Lactobacillus species in both the
vagina and rectum [6]. Due to their anatomical and hormonal
similarity, a transsexual men-to-women population receiving
hormone substitution therapy may be assumed to be comparable
with a general female population for investigations of vaginal
lactobacilli colonisation.
Some pathogenic bacteria infecting the female urogenital
tract emerge from the woman’s own intestinal microbiota
ascending along the perineum to the vagina. Local substitution
with lactobacilli has been shown to significantly enhance the
restoration of the vaginal microflora, leading to a significant
reduction in the recurrence of urinary tract infections [7,8]. Reid
et al. used species-specific PCR-amplification to demonstrately administered lactobacilli preparation to improve the quality of
en. Eur J Obstet Gynecol (2013), http://dx.doi.org/10.1016/
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vagina when administered orally, and found a significant
increase in vaginal lactobacilli in treated subjects versus
controls [9]. Morelli et al. also showed, using genetic identifica-
tion techniques, that L. rhamnosus and L. fermentum strains can
be delivered to the vaginal environment even when taken orally
[10]. Both studies were performed in healthy premenopausal
women. Oral administration of a lactobacilli preparation is a new
concept for the restitution of a normal vaginal microflora [11].
We assume that the rectum could play the important role in
formation of neovaginal microflora in transsexual women and
that selected intestinal lactobacilli also colonise the neovagina,
ascending along the perineum. We undertook this prospective,
randomised, double-blind, placebo-controlled study to deter-
mine whether an orally administered preparation of four
lactobacilli strains exerts a measurable effect on the neovaginal
microflora of transsexual women.
2. Materials and methods
This prospective, randomised, placebo-controlled, double-blind
study was performed with the approval of the Ethics Committee of
the Medical University of Vienna (EK 982/2010) in accordance with
the Declaration of Helsinki and the guidelines for Good Clinical
Practice. Informed consent was obtained from all study partici-
pants prior to enrolment.
We recruited male-to-female transsexual women on an
ongoing basis from among transsexual outpatients of the Medical
University of Vienna. We included all participants that had
undergone sex reassignment surgery (SRS) with the inverted
penile skin flap technique [12] at least 1 year before enrolment. All
transsexual women were being treated according to the Standards
of Care of the World Professional Association of Transgender
Health (WPATH) [13]. Exclusion criteria for this study were clinical
signs of vaginal or urinary tract infection, abnormal neovaginal
discharge, neoplasia, bleeding, diarrhoea, constipation, rectal
pathologies including haemorrhoids, and antibiotic therapy in
the 4 weeks before enrolment.
At baseline, an initial neovaginal smear was obtained from
every male-to-female transsexual woman, after she gave written
informed consent, and transferred to a microscopy slide. Smears
were Gram-stained and evaluated using the entire 10-grade scale
of the Nugent scoring system [14] at an experienced central
laboratory. All participants were randomised using a computer-
generated randomisation list. Transsexual women in the interven-
tion group received oral probiotic capsules twice daily for 7 days,
with each capsule containing four lyophilised Lactobacillus strains
belonging to the species L. crispatus, L. rhamnosus, L. jensenii and L.
gasseri (Table 1). Transsexual women in the control group received
an identical-looking oral potato-maltodextrin-based placebo twice
daily for 7 days. The second and third neovaginal swabs for Nugent
scoring and culture were taken on the day after administration of




L. crispatus LbV88 (DSM 22566) 1  109
L. rhamnosus LbV96 (DSM 22560) 1  109
L. jensenii LbV116 (DSM 22567) 0.2  109
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swabs were agitated in 1 ml sterile phosphate buffered saline (PBS)
for 1 min. An aliquot of 100 ml was diluted10-fold in PBS, and
viable cell counts of presumptive lactobacilli were determined by
plating on MRS agar supplemented with 0.5 g/l cysteine hydro-
chloride and incubating at 37 8C at anaerobic conditions (80% N2,
10% CO2, 10% H2) for 48 h.
The remaining PBS buffer suspensions of the swabs were frozen
at 80 8C and then subjected to DNA extraction and real-time PCR-
based quantification applying the SacaceTM Bacterial Vaginosis
Real-TM Quant kit (Sacace Biotechnologies Srl, Como, Italy) for
RotorGeneTM 3000/6000/Q (Corbett Research, Mortlake, Australia,
Qiagen, Hilden, Germany) according to the manufacturer’s
instructions. The kit includes the DNA extraction procedure from
the specimen and the real-time PCR detection based on fluores-
cent-dye-marked reporter probes specific for the DNA of all
bacteria (Cy5/red), lactobacilli (ROX/orange), Gardnerella vaginalis
(FAM/green) and Atopobium vaginae (JOE/yellow). The results for
presumptive lactobacilli are shown in copies/ml (c/ml).
The primary efficacy variable was the change in the Nugent
score between baseline and the end of treatment (improvement or
no improvement in second swab). The secondary efficacy variable
was the evaluation of the lactobacilli concentration by both culture
and real-time PCR before and after treatment.
2.1. Statistical analysis
The proportion of subjects with score changes between baseline
and the end of the study was compared between treatment groups
using a chi-square test. A p-value <0.05 (two-sided) was
considered statistically significant. Mean Nugent scores were
compared descriptively using the Mann–Whitney U-test.
Because this was a pilot study and there was no historical
estimate of the proportion of participants showing a clinical
benefit from treatment with lactobacilli, the sample size calcula-
tion was based on an estimated percentage on the primary efficacy
endpoint, i.e. a Nugent score improvement. Considering the
potential clinical relevance and assuming an improvement in
the Nugent score in more than 50% of women in the intervention
group and a possible improvement in a maximum of 5 women in
the control group (16.7%), a sample size of 30 subjects per group
was considered sufficient to show a statistically significant
superiority with a power of at least 80%. SPSS version 11.0 was
used for statistical analyses.
3. Results
Between December 2011 and March 2012, a total of 75 male-to-
female transsexual women of Caucasian origin were screened for
inclusion into the study. The mean age of the women was 41.2  13
years, mean height was 176.5  6.4 cm, mean weight was
82.3  19.9 kg; and the mean time since SRS was 5.2  4.8 years.
The flow of participants through the study is illustrated in Fig. 1.
Sixty transsexual women fulfilling all eligibility criteria were
included in the final analyses, 33 in the intervention group and 27
in the control group. Based on the first neovaginal smear, a Nugent
score of 0–3 was identified in 10 women (30%) in the intervention
group and in 8 women (30%) in the control group. An abnormal
neovaginal bacterial microflora with a Nugent score of 4–10 in the
first smear was detected in 23 women (70%) in the intervention
group and in 19 women (70%) in the control group, without a
statistical difference between the groups (p < 0.371).
Analysis of the first swab showed a median Nugent score of 5 in
both groups. Analysis of the second swab after one week of oral
lactobacilli administration showed a median Nugent score of 5 in
the intervention group and 6 in the control group. Another twoly administered lactobacilli preparation to improve the quality of
en. Eur J Obstet Gynecol (2013), http://dx.doi.org/10.1016/
Fig. 1. Flow of participants through the study.
Table 2
Improvement of Nugent score between swabs 1 and 2 and between swabs 2 and 3 in




N % N % N %
Swab 1 vs. 2a
Significant improvement 16 48.5 4 14.8 20 33.3
No significant improvement 17 51.5 22 81.5 39 65
Not evaluable 0 0 1 3.7 1 1.7
Total 33 55.0 27 45.0 60 100.0
Swab 2 vs. 3b
Significant improvement 7 21.2 9 33.3 16 26.7
No significant improvement 25 75.8 15 55.6 40 66.7
Not evaluable 1 3 3 11.1 4 6.7
Total 28 53.8 24 46.2 52 100.0
a Chi Square Test: p = 0.006.
b Chi Square Test: p = 0.204.
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Comparison of differences in Nugent score between the first and
second swabs showed a significant difference (p < 0.02) of 0.18 in
the intervention group and +0.92 in the control group.
A significant improvement in the Nugent score was seen in 16
women (48.5%) in the intervention group and in 4 women (14.8%)
in the control group (p < 0.006; Table 2).
The differences in presumptive lactobacilli concentrations
between the first and second swabs were measured by culture
in both groups. In the intervention group, an increase by
10,000  600 colony forming units (CFU) of presumptive lactobacilli
was seen, compared with an increase by 1600  100 CFU in the
control group (p < 0.0001).When measured by real-time PCR (c/ml),
lactobacilli increases of 1400  100 c/ml in the intervention groupPlease cite this article in press as: Kaufmann U, et al. Ability of an oral
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between the first and second swabs.
When all transsexual women with a normal neovaginal
microflora Nugent score of 0–3 at baseline were excluded
(n = 18), an improvement in the Nugent score was seen in the
intervention group (n = 23), but not in the control group (n = 19).
When looking only at women with baseline BV (i.e., a Nugent score
>7; n = 22), a change to an intermediate microflora was seen in the
intervention group but not in the control group.
4. Comment
The results of this prospective randomised controlled study
show that oral administration of L. crispatus, L. rhamnosus, L.
jensenii and L. gasseri significantly improved the neovaginal
microflora and reduced the Nugent score in a group of transsexual
women. Also, the microflora was significantly enriched with
lactobacilli after oral supplementation compared to placebo. The
combination of Lactobacillus spp. used in this study is the only one
published as the physiologic mixture of female vaginal lactobacilli
microflora [15]. We used an innovative probiotic lactobacilli
composition containing four of the most common lactobacilli
isolated from the microflora of healthy women’s vaginas [15] for
treatment of 7 days’ duration. Weyers et al. reported that
colonisation of the neovagina of transsexual women with
lactobacilli is minimal [1,2]. According to Nugent, an intermediate
vaginal microflora is defined by a reduction and BV by an absence
of lactobacilli with the presence of Gram negative bacteria in both
cases [14]. The small number of publications on the standard
neovaginal microflora and the near lack of evidence of lactic acid
bacteria in the transsexual genital tract area are a challenge for
investigations in this population. While transsexual women have
normal female anatomy, there is no uterus and no connection of
the neovagina to the pelvic cavity, which is why the risk of pelvic
inflammatory disease is low. We were therefore able to include all
transsexual women without clinical signs of infection, including
those with asymptomatic BV. To our knowledge, this is the first
study to allow a direct assessment of the comparative effect of oral
probiotic lactobacilli and placebo on BV.
The gastrointestinal tract plays an important role as a reservoir
for the vaginal colonisation by Lactobacillus spp. [4–6]. Both vaginal
and oral applications of lactobacilli have been shown to improve
the vaginal microflora of both pre- and post-menopausal women
[3,9–11]. The results of this study indicate that oral lactobacilli
have a similar effect on the neovaginal flora of transsexual women.
Descriptive analyses of the difference in Nugent score showed a
reduction of 0.18 in the intervention group and an increase of
+0.92 in the control group.
We found a significant improvement in the Nugent score in
48.5% of women in the intervention group, compared with only
14.8% in the control group. Lactobacilli concentrations assessed by
culture and real-time PCR were 5–6 times higher in the
intervention than in the control group, with these differences
being statistically significant.
The sample size calculation in this study was based on
neovaginal lactobacilli colonization rates of up to 4% reported in
the literature [1,2]. In the present study, however, 30% of the
women in both the intervention and control groups had a normal
lactobacillus microflora (Nugent score 3). This was an unexpect-
ed finding contrasting with the current literature [1,2]. Because
oral lactobacillus supplementation cannot be expected to change a
neovaginal microflora dominated by lactobacilli, this unexpectedly
high proportion of women with a normal lactobacillus flora may
have led to an underestimation of the treatment effect. We
therefore carried out a subgroup analysis including only women
with a baseline Nugent score above 4, corresponding to either anly administered lactobacilli preparation to improve the quality of
en. Eur J Obstet Gynecol (2013), http://dx.doi.org/10.1016/
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with oral lactobacilli, we found an improvement in the Nugent
score in the intervention group and no change in the control group.
The results of this subgroup analysis are comparable with the
results of one of our earlier studies on the effect of lactobacilli on
postmenopausal women, which showed an improvement in
Nugent scores [11]. In contrast to the previous study with a
lactobacilli treatment duration of 14 days, however, the improve-
ment in the current was already seen after 7 days of oral
lactobacilli. The renewed increase of the Nugent score two weeks
after the end of oral therapy indicates that extended oral probiotic
therapy may be necessary to maintain a lactobacilli-dominated
microbiota.
This study had several limitations. With a specific study group
of male to female transsexual women and very limited number of
patients visiting our clinic we could observe only a small sample
size in our study. The therapy duration was limited to 7 days: we
assume that longer treatment with probiotics could obtain a better
outcome. Microbiology analyses of CFU’s and c/ml were presented
only for presumptive lactobacilli. In the next step we will include
other bacteria with similar colony characteristics, such as
Gardnerella vaginalis and Atopobium vaginae to present more
detailed data. This study is first to observe male to female
transsexual women using probiotics and we are aware of our initial
oversights.
In summary, this first study on the effect of oral probiotics on
the neovaginal microflora of transsexual women found that oral
administration of lactobacilli resulted in a significant improve-
ment in the Nugent score and a change of the neovaginal
microflora. These observations are consistent with previous results
obtained in pre- and post-menopausal women. The increase of the
Nugent score two weeks after the end of oral therapy provides a
possible need for extended oral probiotic therapy for maintenance
of a lactobacilli-dominated microbiota. In addition, this study
shows that even asymptomatic BV may be improved to a normal
microflora by 7 days of oral supplementation of lactobacilli.
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